the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Biotechnology Market Research

<< Previous Page:   1   2   3   4   5   6   7   8   9   10   11   12   Next >>
 
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment Overview
Table of Contents Published: 2009/08 Published by: Insight Pharma Reports
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment presents an analysis for the current state of mAb drug development. It identifies more than 250 therapeutic products now in clinical trials, which are largely concentrated in the areas of ...

Ion Channel Modulator Pipelines: Targets and Agents in Development Overview
Table of Contents Published: 2009/08 Published by: Insight Pharma Reports
Ion Channel Modulator Pipelines: Targets and Agents in Development provides a comprehensive analysis of the ion channel modulator pipeline, breaking it down by company, ion channel type, and therapeutic indication. ...

Strategic Analysis of the Healthcare Industry in Zambia
Table of Contents Published: 2009/08 Published by: Frost & Sullivan
This research service presents an in-depth analysis of the Zambian healthcare industry. It provides a general insight into processes of regulations, medical insurance, healthcare procurement and financing. ...

North American and Western European Biopesticides Markets
Table of Contents Published: 2009/08 Published by: Frost & Sullivan
The North American and the European biopesticides market is an emerging market with growing demand of products. There are many regulations banning the sales of existing chemistries in synthetic chemical pesticides which is actually driving the need to dev ...

Competitor Analysis: Targeted Therapy of Hepatitis C
Table of Contents Published: 2009/08 Published by: La Merie
The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2009. Purchase of the downloadable pdf re ...

Uncovering Biomarker and Diagnostic Opportunities in Immune and Inflammatory Diseases
Table of Contents Published: 2009/08 Published by: Decision Resources, Inc.
Despite the robust drug market for immune and infl ammatory diseases and their high prevalence, diagnostics associated with these diseases do not constitute a large marketplace. ...

Coagulation Factors 2009: Target Pipeline and Competitor Benchmark Analysis
Table of Contents Published: 2009/08 Published by: La Merie
The Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis report is the most complete and up-to-date evaluation and assessment of the recombinant and plasma-derived coagulation factor pipelines. The authors analyze and assess the targ ...

Global Protein Therapeutics Market Analysis
Table of Contents Published: 2009/08 Published by: RNCOS E-Services Pvt. Ltd.
This report provides extensive information and rational analysis of the global protein therapeutics market. It includes detailed study of factors fueling growth in the protein therapeutics market to help clients gain deeper insight of the current and futu ...

Pipeline Insight: Prostate Cancer Molecular targeted therapies will fulfill unmet needs in castration-resistant disease
Table of Contents Published: 2009/08 Published by: Datamonitor
Incidence of prostate cancer in the seven major markets will be just over 422,000 in 2009, indicating high patient potential for drug developers to invest in. There are currently 136 agents in development for prostate cancer, two-thirds of which are novel ...

Commercial Insight: Molecular Targeted Cancer Therapies Leading companies will hold onto competitive advantage in high growth market
Table of Contents Published: 2009/08 Published by: Datamonitor
Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent ...

Emerging Therapeutic Segments in the European Biopharmaceutical Markets
Table of Contents Published: 2009/08 Published by: Frost & Sullivan
The research services provides an analysis of the European markets for emerging therapeutic areas such as antisense therapy, gene therapy and cell therapy. The research services segments the market based on the drug classes. ...

Expanding Applications of Personalized Medicine: Use of biomarkers in prognostic, predictive and pharmacogenetic tests in a targeted approach
Table of Contents Published: 2009/08 Published by: Business Insights
1Over the past decade, several significant advances in targeted therapies have improved the ability to treat certain cancers, the most notable early successes been trastuzumab in breast cancer and imatinib in chronic myelogenous leukemia. Recently, severa ...

Bioarrays for Life Science Research, Diagnostics and Drug R&D
Table of Contents Published: 2009/08 Published by: Takeda Pacific
This report discusses new bioarray products reaching the market including DNA and RNA products such as high-density arrays, tiling, copy number variation, SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation, microRNA, sequence-ca ...

Infectious Disease Diagnostic Markets
Table of Contents Published: 2009/08 Published by: Kalorama Information
This report focuses on products used for the diagnosis of bacterial and viral infections. The major consideration is given to bacterial infections because (a) they are the most frequent type of infections, and (b) the practical aspects of diagnosis and th ...

DNA Sequencing Equipment and Services Markets, 2nd Edition
Table of Contents Published: 2009/08 Published by: Kalorama Information
Since the last edition of Kalorama Information' s DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situati ...

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Table of Contents Published: 2009/08 Published by: Kalorama Information
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and other areas in the world and the possibility o ...

Biotechnological innovations in the pharmaceutical industry in Poland 2009
Table of Contents Published: 2009/08 Published by: PMR
Biotechnological innovations in the pharmaceutical industry in Poland 2009 provides a comprehensive overview of the biotechnology market in Poland. Covering major industry trends and events, it touches on both domestic and international occurrences that h ...

Asia Pacific Biotechnology Market (2008-2012)
Table of Contents Published: 2009/08 Published by: RNCOS E-Services Pvt. Ltd.
According to our new research report, Asia Pacific Biotechnology Market (2008-2012), the Asia-Pacific biotech market is projected to grow at a CAGR of around 14% during 2010-2012. Currently, the industry is driven by new developing markets like Malaysia a ...

Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations
Table of Contents Published: 2009/08 Published by: BioInformatics, LLC
In this study, scientists elaborate on processes and techniques they use to do epigenetics research, problems with protocols and antibodies, changes expected in the time/effort devoted to epigenetics research over the next couple of years and the estimate ...

Cell-Based Assays for Drug Discovery
Table of Contents Published: 2009/08 Published by: Trimark Publications
The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications th ...

Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
Table of Contents Published: 2009/07 Published by: Datamonitor
'Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players' is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies. ...

Delivering RNAi-based Therapeutics & Diagnostics: Challenges & Opportunities
Table of Contents Published: 2009/07 Published by: PharmaVision & Espicom
The market for RNAi-based therapeutics is forecast to grow from 2013 onwards, as the first products enter the marketplace, to generate sales in excess of US$2.9 billion by 2020. The first siRNA-based therapeutics will capitalize on the demand to treat vir ...

MicroRNA Research Trends 2009 Market Report
Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Research Market Trends. The focus of this report is to document the technical and commercial trends operative in the microRNA research space with emp ...

European Markets for Orthopedic Biomaterials 2009
Table of Contents Published: 2009/07 Published by: Millennium Research Group
This market comprises hyaluronic acid viscosupplementation, bone graft substitutes, and knee cartilage repair products sold in Austria, France, Germany, Italy, Spain, and the UK. ...

Data Mining in Drug Development and Translational Medicine Overview
Table of Contents Published: 2009/07 Published by: Insight Pharma Reports
The biopharmaceutical industry is grappling not only with sheer data volume but with the ability of researchers to extract information through identification and contextual analysis of those data that are relevant to a particular set of investigations. ...

Competitor Analysis: PI3K-AKT-mTOR Inhibitors
Table of Contents Published: 2009/07 Published by: La Merie
The report includes a compilation of current active projects in research and development of PI3K-AKT-mTOR inhibitors in oncology and other indications. ...

Competitor Analysis: HDAC Inhibitors
Table of Contents Published: 2009/07 Published by: La Merie
The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. ...

Best Practices in Utilizing Health Outcomes Data for Promotional/Commercial Efforts
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Health Outcomes data has become increasingly important to the success of biotechnology and pharmaceutical companies. This study aims to discover and collect best practices in how companies use and review the use of Health Outcomes data in promotional/comm ...

Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payers Access & Insights
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This Best Practices, LLC benchmarking report identifies the Market Research structures and activities that best support the Managed Markets function in gaining payer access and insights around pharmaceutical products, as well as captures executives' best ...

The SADC Healthcare Regulatory Environment
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service identifies and discusses the regulatory framework (including that of medical waste management and medical insurance) of the Southern African Development Communities (SADC) countries. ...

Molecular Diagnostics Market: Trends and Opportunities
Table of Contents Published: 2009/07 Published by: Koncept Analytics
The report titled Molecular Diagnostics Industry: Trends and Opportunities analyzes the molecular diagnostics segment of IVD industry. The study explores the potential business opportunities that exist in the molecular diagnostics industry. Further, facto ...

CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer r ...

Biosimilars and Biobetters: Positioning for a New Market
Table of Contents Published: 2009/07 Published by: Biophoenix Limited
This new and timely report analyzes the emerging market for first- and second-generation biosimilars. The market can best be understood in the context of the established $110 billion biologics business, which is therefore comprehensively reviewed. Current ...

Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases
Table of Contents Published: 2009/07 Published by: Decision Resources, Inc.
Better diagnostics, the means to treat earlier stage-disease, disease-modifying therapies, and disease prevention are the holy grails of autoimmune and infl ammatory disease drug development. However, basic science and redundant biological pathways are ho ...

Small Molecule Kinase Inhibitors
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. ...

Nanomedicine
Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc.
This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of 2006 through 201 ...

2008/2009 Biotechnology Research Review
Table of Contents Published: 2009/07 Published by: BCC Research
The global economic downturn that began in 2008 has slowed growth in nearly all technology sectors, including biotechnology markets. Nonetheless, the high value that biotechnology products can deliver, and the long-term growth potential of the sector will ...

Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Table of Contents Published: 2009/07 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies ...

Managing Sales Training to Accelerate Speed to Productivity
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Though effective sales training is a valuable investment, it is being cut back out of economic necessity. Given this reality and the fluctuation of company needs and competitive pressures, training roles and responsibilities, resources, contents and evalu ...

Best Practices in Designing Effective Brand Teams: Brand Governance and Brand Team Management
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Designing Effective Brand Teams: Brand Governance and Brand Team Management explores how high-performing brand teams coordinate, communicate, and execute critical activities to drive brand growth. It yields insights into how pharmaceutical and biotech com ...

Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of the commercial and government payers in the highly-influential Managed Markets sector. In response, savvy bio-pharmaceutical companies are seeking to ...

MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report
Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd.
This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a Paradigm for the development of M ...

U.S. CRO Markets - Key Therapeutic Areas
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service provides a detailed overview and analysis of key therapeutic areas in the U.S. CRO Market. The research service includes a detailed analysis of market trends, industry challenges and key therapeutic areas. Revenue forecasts from 2010 ...

Strategic Analysis of U.S. Molecular Cytogenetics Markets
Table of Contents Published: 2009/07 Published by: Frost & Sullivan
This research service provides a strategic analysis of the molecular cytogenetics market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key c ...

Optimizing Key Opintion Leader Relationships: Best Practices in KOL Management
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This report identifies the organizational structures, management strategies and tactics, and critical success factors associated with KOL management excellence. Pharma executives can use this benchmarking research to learn best practices in KOL management ...

Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
As companies compete for the attention of physicians, key opinion leaders (KOLs) and thought leaders, they increasingly use medical science liaisons (MSLs) to build and strengthen KOL relationships. As laws continue to restrict relationships between pharm ...

Using Public Relations to Launch, Grow and Extend Your Brands
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This Best Practices, LLC benchmarking report identifies the most current and effective PR tools and calls-to-action, and explores how top companies align these tactics with each stage of a product' s lifecycle. Pharmaceutical executives and directors can ...

Building an Effective Regulatory Relationship with the FDA
Table of Contents Published: 2009/07 Published by: Best Practices, LLC
This report delivers benchmarks and insights that identify approaches for understanding and effectively interacting with the FDA. The research is based on detailed survey data from Regulatory Affairs executives and managers from 15 top pharmaceutical comp ...

Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform
Table of Contents Published: 2009/07 Published by: Cutting Edge Information
Of all factors contributing to product success, payer access could be the most critical. Without the best reimbursement status for a drug, the investments your company made during drug development may end up as a lost cause. Securing Market Access: Reimbu ...

Personalized Medicine: Technologies and the Global Market
Table of Contents Published: 2009/07 Published by: BCC Research
Personalized diagnosis and treatment - or personalized medicine - is the most recent trend in the multibillion - dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order t ...


<< Previous Page:   1   2   3   4   5   6   7   8   9   10   11   12   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.